Taking prescribed beta blockers during hematopoietic stem cell transplantation may increase mortality risk due to suppression of signals from nerves that promote bone marrow regeneration, according to ...
Key Insights Stem's significant retail investors ownership suggests that the key decisions are influenced by... SAN FRANCISCO, January 16, 2025--Stem, Inc. (NYSE: STEM), a global leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback